Inhibiting Sperm Protein Causes Infertility

Two drugs targeting a protein in sperm cause reversible infertility in male mice, providing new hope for a male contraceptive.

Written byKaren Zusi
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, ZAPPYS TECHNOLOGY SOLUTIONSResearchers have identified a sperm-specific protein, essential for fertilization, that is negatively affected by US Food and Drug Administration–approved drugs in male mice. The results, which the authors contend show promise for a male contraceptive, were published last week (October 1) in Science.

Researchers from Osaka University and Tsukuba University in Japan focused on the calcineurin protein, which exists in multiple forms throughout the body. They followed previous lines of evidence indicating that sperm produce a specific form of calcineurin.

The team created a set of knockout mice that lacked the sperm-specific form of the enzyme and observed the animals’ sexual activity. While the knockout males were able to ejaculate normally, they failed to impregnate any of the normal female mice in the study. Analyzing the semen, the researchers discovered that the midsection of the sperm cells’ flagella were too rigid to help the sperm fully penetrate and fertilize the eggs.

The researchers then gave normal mice a set of calcineurin-inhibiting medications. Over a five-day course of drug ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies